Australian Trachoma Surveillance Report 2014

National Results

Page last updated: 30 October 2015

National results – Figures

National results –Tables



National results – Figures

Figure 1.1 Trachoma prevalence in children aged 5-9 years in at-risk communities in Australia, 2014

Figure 1.1 is a map of Australia, divided by states and territories in regions where trachoma prevalence in children aged 5 to 9 years are recorded in 6 categories:
1. Areas not at-risk of trachoma or where no data has been collected are Qld, Vic, Tas, the South West corner of WA, the South East corner of South Australia and NSW (except for the Western and Far Western regions)
2.  No Trachoma was identified in Western and Far Western region in NSW
3. Less than 5% are in the regions of Darwin Rural, East Arnhem, and Katherine in the NT,  Far North and the Eyre and Western region in South Australia, the Kimberley region in WA
4. Between 5% and 10% are in the regions of the Goldfields in WA and the Anangu Pitjantjatjara Yankunytatjara (APY) Lands in South Australia
5. Between 10% and 20% are in the Midwest region in WA
6. Greater than 20% are in the Barkly and Alice Springs Remote regions in the NT.

Figure 1.2 Number of communities at risk, by year and jurisdiction, Australia, 2007–2014

Top of page Figure 1.2 is a Line graph illustrating the number of communities at-risk of trachoma for the years 2007 to 2014 in the NT, South Australia, WA and NSW.
NT data indicates a slight decreasing trend from 85 communities in 2007 to 78 communities in 2014.
South Australia indicates data at around 70 at-risk communities for the period 2007 to 2011 and then declines significantly to 38 communities in 2012, with a further decline to 22 communities in 2013, and to 13 in 2014.
WA data indicates a gradual increasing trend from 72 communities in 2007 to 86 communities in 2010, then decreases to 71 communities in 2013 and 59 in 2014.
NSW data indicates 10 communities potentially at-risk in 2013 and 2014.

* In 2014 NSW communities have been designated as "potentially at-risk" for the purposes of a mapping exercise

Top of page

Figure 1.3 Number of at-risk communities by jurisdiction, according to trachoma control strategy implemented, Australia, 2014

Figure 1.3 is a Stacked bar graph illustrating the number of at-risk communities, per jurisdiction that were screened and/or treated under the Trachoma Control Strategy in the NT, South Australia, WA and NSW. 
The NT column indicates that of 79 communities: 15 did not require screening or treatment; 21 communities were screened; 24 communities were screened and treated; and 19 communities received treatment only.
The South Australia column indicates that of 13 communities:10 were screened; and 3 communities were screened and treated.
The WA column indicates that of 58 communities:  39 were screened; and 19 communities were screened and treated.
The NSW column indicates that of 10 communities, all were screened.Top of page

Figure 1.4 Population screening coverage in children aged 5-9 years in communities that were screened for trachoma by jurisdiction, Australia, 2014

Figure 1.4 is a Bar graph illustrating coverage by percentage of children aged 5 to 9 years in communities that were screened in the NT, South Australia, WA and NSW.
NT indicates 92%.
South Australia indicates 87%.
WA indicates 91%.
NSW indicates 63%.Top of page

Figure 1.5 Proportion of screened children aged 5-9 years who had a clean face, by year and jurisdiction, Australia, 2007–2014

Figure 1.5 is a Line graph illustrating the proportion of screened children aged 5 to 9 years who had a clean face for the years 2007 to 2014 in the NT, South Australia, WA. NSW is included for the years 2013 and 2014.
The data for NT, South Australia, and WA remained between 70-90% across all years. 
The NT indicates a decrease from 85% in 2007 to 70% in 2008 and then increases again gradually to 86% in 2014.
South Australia indicates a decrease from 88% in 2007 to 77% in 2008, followed by an increasing trend to 90% in 2012, decreasing to 84% in 2014.
WA indicates data consistently around 80% from 2007 to 2010, then decreases to 74% in 2011, increases to 81% in 2012, decreases to 73% in 2013 and increases to 79% in 2014.  
NSW recorded 96% for 2013 and 100% in 2014. No other years are indicated for NSW.Top of page

Figure 1.6a Observed trachoma prevalence among screened children aged 5-9 years, by year and jurisdiction, Australia, 2007–2014

Figure 1.6a is a Line graph illustrating the observed trachoma prevalence trends in children aged 5 to 9 in the NT, South Australia, WA for the years 2007 to 2014. NSW is included for the years 2013 and 2014.
The prevalence recorded for NT starts at 14% in 2007, spikes at 26% in 2008, decreases and remains stable at 15% in 2009 and 2010, then slowly decreases to 2.4% in 2013, increasing again to 5.5% in 2014.
The prevalence recorded for South Australia starts at 14% in 2007, dips to 2% in 2008, returns to 14% in 2009, and decreases to under 5% for the years 2011 to 2014. There was no data recorded for South Australia in 2010.
WA has a consistent prevalence of around 15% for 2007 to 2009 with a decreasing trend to 2% in 2014.
NSW recorded 0.5% of trachoma prevalence in 2013 and 0% in 2014.Top of page

Figure 1.6b Trachoma prevalence among children aged 5-9 years, by year and jurisdiction, Australia,* 2007–2014

Figure 1.6b is a Line graph illustrating the projected trachoma prevalence trends in children aged 5 to 9 in the NT, South Australia, WA for the years 2007 to 2014. NSW is included for the years 2013 and 2014. 
The prevalence recorded for NT is at 14% in 2007, spikes at 26% in 2008, decreases and remains stable at 15% in 2009 and 2010, then slowly decreases to 4% in 2012, increasing again to 5.9% in 2014;
The prevalence recorded for South Australia starts at 14% in 2007, dips to 2% in 2008, returns to 14% in 2009, and decreases to under 5% for the years 2011 to 2014. There was no data recorded for South Australia in 2010.
WA has a consistent prevalence of 15% for 2007 to 2009, with a decreasing trend to 2.8% in 2014.
NSW recorded prevalence of 0.5% in 2013 and 0% in 2014.

* Including communities that screened in 2014 and those that were not required to screen in 2014, in accordance with guidelines (see methodology)

Top of page

Figure 1.7 Number of screened at-risk communities* according to level of trachoma prevalence in 5-9-year-old children, by jurisdiction, Australia, in 2014

Figure 1.7 is a Stacked bar graph illustrating the number of screened at-risk communities, per jurisdiction, in the NT, South Australia, WA and NSW.
The NT column indicates that of 78 communities: 14 had greater than or equal to 20%; 14 had greater than or equal to 10% but less than 20%;  10 had greater than or equal to 5% but less than 10%;  6 had greater than 0% but less than 5% trachoma; and  34 had no trachoma.
The SA column indicates that of 13 communities: 1 had greater than or equal to 20%; 1 had greater than or equal to 10% but less than 20%; 1 had greater than 0% but less than 5% trachoma; and  10 had no trachoma.
The WA column indicates that of 59 communities: 2 had greater than or equal to 20; 4  had greater than or equal to 10% but less than 20%; 2 had greater than or equal to 5% but less than 10%; 6 had greater than 0% but less than 5% trachoma; and  45 had no trachoma.
The NSW column indicates that of 10 communities, all 10 had no trachoma.

* Including communities in the NT that screened in 2014 and those that were not required to screen in 2014, in accordance with guidelines (see methodology)

Top of page

Figure 1.8 Number of communities according to number of years* of trachoma prevalence under 5%, by jurisdiction* in Australia, 2014

Figure 1.8 is a Stacked bar graph illustrating the number of years that trachoma prevalence has been kept under 5% over a 5 year period for each jurisdiction (NT, South Australia, WA and NSW).
The NT column indicates that from a total of 39 communities, there are: 8 communities for 1 year; 5 communities for 2 years; 5 communities for 3 years; 5 communities for 4 years; and 16 communities for 5 years. 
The South Australia column indicates that from a total of 11 communities there are: 3 communities for 1 year; 2 communities for 2 years;  4 communities for 4 years; and 2 communities 5 years.
The WA column indicates that from a total of 49 communities, there are: 9 communities for 1 year; 10 communities for 2 years; 11 communities for 3 years;  10 communities for 4 years; and  9 communities for 5 years.
The NSW column indicates there is 1 community that recorded trachoma prevalence under 5% for 1 year.

* 5 years with a prevalence below 5% classifies a community as not at risk of trachoma
† Including communities that screened in 2014 and those that were not required to screen in 2014, in accordance with guidelines (see methodology)

Top of page

Figure 1.9 Number of doses of azithromycin administered for the treatment of trachoma by jurisdiction in Australia, 2007–2014

Figure 1.9 is a Line graph indicating the number of doses of azithromycin administered for the treatment of trachoma in the NT, South Australia, and WA between 2007 and 2014. NSW is included for the years 2013 and 2014.
The NT data indicates a significantly greater number of doses administered, in comparison to the other jurisdictions. 
The NT data indicates 317 doses were administered in 2007, increasing sharply to 3940 doses in 2008, decreasing to 3270 doses in 2009, and with a steep increase over the years to 9232 doses in 2013, decreasing to 7800 in 2014.
The South Australia data indicates 20 doses were administered in 2007, 7 in 2008, 19 in 2009, there is no data for 2010, 468 doses in 2011, 112 in 2012, 203 in 2013 and 200 in 2014.
The WA data indicates shows 1401 doses were administered in 2007, a peak of 2917 doses in 2008, decreasing to 1181 doses in 2009, and a steady decrease to 700 doses in 2012, increasing to 759 doses in 2013, and 1798 in 2014.
The NSW data indicates 25 doses were administered in 2013 and 0 doses in 2014.Top of page

National results –Tables

Table 1.1 Trachoma control delivery, Australia, 2014
Number of communities
Northern Territory
South Australia
Western Australia
New South Wales
Total
Not at-risk
*In 2014 NSW communities have been designated as “potentially at risk” for the purposes of a mapping exercise
Communities treated without screening in 2014 as per revised guideline instructions
At risk* (A)
78
13
59
10
160
0
Requiring screening for trachoma (B)
44
13
58
10
125
0
Screened for trachoma (C)
44
13
58
10
125
4
Requiring treatment only (D)
19
0
1
0
20
0
Treated (E)
19
0
1
0
20
0
Screened and/or treated for trachoma (F = C+E)
63
13
59
10
145
4
Requiring neither screening or treatment for trachoma (G=A-B-D)
15
0
0
0
15
0
Top of page
Table 1.2 Trachoma screening coverage, trachoma prevalence and clean face prevalence, Australia, 2014
Northern Territory
South Australia
Western Australia
New South Wales
Total
Not at risk
*Jurisdictional estimate
In communities that were screened for trachoma
Number of communities screened
44
13
58
10
125
4
Age group (years)
5-9
5-9
5-9
5-9
5-9
5-9
Children examined for clean face
1804
681
1685
71
4241
370
Children with clean face
1545
569
1333
71
3518
324
Clean face prevalence (%)
86
84
79
100
83
88
Estimated number* of Aboriginal children in communities
1937
783
1724
396
4840
402
Children screened for trachoma
1789
681
1565
249
4284
367
Trachoma screening coverage (%)
92
87
91
63
89
91
Children with active trachoma
99
27
32
0
158
12
Active trachoma prevalence (%)
5.5
4.0
2.0
0.0
3.7
3.3
Active trachoma prevalence using projected data (%)
5.9
4.0
2.9
0.0
4.7
Top of page
Table 1.3 Treatment strategies, by jurisdiction, Australia, 2014
Number of communities
Northern Territory
South Australia
Western Australia
New South Wales
Total
*Due to resource limitations
Required treatment for trachoma
43
3
20
0
66
Treated for trachoma
43
3
20
0
66
Screened and treated
24
3
19
0
46
Received treatment only
19
0
1
0
20
Received 6-monthly treatment
6
0
0
0
6
Did not require treatment
38
10
39
10
97
Treated active cases and households
17
3
18
0
38
Treated the whole of community
26
0
3
0
29
Not treated according to CDNA guidelines*
1
0
0
0
1
Top of page
Table 1.4 Trachoma treatment coverage, Australia, 2014
Northern Territory
South Australia
Western Australia
Total
* As per guidelines
Age group (years)
0-4
5-9
10-14
15+
All
0-4
5-9
10-14
15+
All
0-4
5-9
10-14
15+
All
0-4
5-9
10-14
15+
All
Active cases requiring treatment
11
110
25
..
146
1
27
1
..
29
9
32
12
..
53
21
169
38
..
228
Active cases who received treatment
11
102
21
..
134
1
27
5
..
29
5
31
10
..
93
17
160
32
..
209
Active cases who received treatment (%)
100
93
84
..
92
100
100
100
..
100
56
97
83
..
99
81
95
84
..
92
Estimated contacts requiring treatment
926
1104
1002
5622
8654
16
15
26
118
175
193
220
207
317
717
1135
1339
1235
6900
10609
Number of contacts who received treatment
822
1028
907
4914
7671
16
15
26
114
171
191
218
201
315
666
1029
1261
1134
6170
9594
Estimated contacts who received treatment (%)
89
93
91
87
89
100
100
100
97
98
99
99
97
99
93
91
94
92
89
90
Total number of doses of azithromycin delivered
833
1130
928
4914
7805
17
42
27
114
200
196
249
211
315
759
1046
1421
1166
6170
9803
Estimated overall treatment coverage (%)
89
93
90
87
89
100
100
100
97
98
97
99
96
99
94
90
94
92
89
90
Doses administered in communities that were treated without screening*
566
722
614
3426
5328
..
..
..
..
..
98
115
95
743
1051
664
837
709
4169
6379
Doses administered six-monthly*
120
137
123
644
1024
..
..
..
..
..
..
..
..
..
..
120
137
123
644
1024
Top of page
Table 1.5 Trichiasis screening coverage, prevalence and treatment among Aboriginal adults, Australia, 2014
Northern Territory
South Australia
Western Australia
Total
* Population estimate limited to trachoma endemic regions and does not take into account changing endemic regions over time and transiency between regions
Number of adults examined limited to numbers reported. This number does not account for adults who may be examined in routine adult health checks, and may also include multiple screening
Number of communities screened for trichiasis
67
13
No data
143
Age groups
15-39
40+
15-39
40+
15-39
40+
15-39
40+
15+
Estimated population in region*
25483
7231
5084
1827
10712
3538
41279
12596
53875
Adults examined
2573
2279
717
1092
1056
1780
4346
5151
9497
With trichiasis (% of adults examined)
2
(0.08)
25
(1.1)
1 (0.1)
11
(1)
0
11
(0.1)
3
(0.08)
47
(0.9)
50
(0.5)
Offered ophthalmic consultation
1
13
1
11
0
11
2
35
37
Declined ophthalmic consultation
1
7
0
1
0
3
1
11
12
Surgery in past 12 months
0
12
1
3
0
1
1
16
17
Top of page